XML 92 R67.htm IDEA: XBRL DOCUMENT v3.3.1.900
Schedule I Condensed Parent Company Financial Statements (Details 4) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating activities                      
Net income (loss) $ 24,000 $ 60,265 $ (75,192) $ (78,909) $ 128,771 $ 19,123 $ 56,507 $ 74,969 $ (69,836) $ 279,370 $ (91,044)
Financing activities                      
Cash and cash equivalents at beginning of period       554,831       598,108 554,831 598,108 515,164
Cash and cash equivalents at end of period 275,004       554,831       275,004 554,831 598,108
Parent company                      
Operating activities                      
Net income (loss)                 (69,836) 279,370 (91,044)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:                      
Equity in (earnings) losses of subsidiaries                 7,464 (311,157) 64,552
Equity-based compensation                 75,267 79,741 69,101
Amortization                 3,190 3,188 3,017
Other                 2,704 269  
Changes in assets and liabilities:                      
(Increase) decrease in prepaid expenses and other                 (34) 89 (149)
(Increase) decrease due to/from related party                 1,224 (3,915) 4,134
Increase in accounts payable and accrued liabilities                 2,721 10,593 794
Net cash provided by operating activities                 22,700 58,178 50,405
Investing activities                      
Investment in subsidiaries                 (293,545) (208,879) (133,066)
Net cash used in investing activities                 (293,545) (208,879) (133,066)
Financing activities                      
Net proceeds from issuance of senior secured notes                 206,774 294,000  
Purchase of treasury stock                 (18,110) (11,096) (13,101)
Deferred financing costs                 (9,030) (1,401) (1,720)
Net cash provided by (used in) financing activities                 179,634 281,503 (14,821)
Net increase (decrease) in cash and cash equivalents                 (91,211) 130,802 (97,482)
Cash and cash equivalents at beginning of period       $ 165,894       $ 35,092 165,894 35,092 132,574
Cash and cash equivalents at end of period $ 74,683       $ 165,894       $ 74,683 $ 165,894 $ 35,092